Shin-Ichiro Hirai
SANTEN PHARMACEUTICAL CO., LTD.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shin-Ichiro Hirai.
Oxidative Medicine and Cellular Longevity | 2017
Koji Ohashi; Masaaki Kageyama; Katsuhiko Shinomiya; Yukie Fujita-Koyama; Shin-Ichiro Hirai; Osamu Katsuta; Masatsugu Nakamura
Retinal pigment epithelium (RPE) degeneration is a crucial event in dry age-related macular degeneration and gyrate atrophy. The polyamine spermidine has been shown to induce RPE cell death in vitro. The present study aimed to establish a novel in vivo model of spermidine-induced RPE degeneration and to determine whether spermidine-induced RPE cell death involves oxidative mechanisms. In this study, spermidine caused ARPE-19 cell death in a concentration-dependent manner. This effect was prevented by removal of serum from the culture medium or treatment with amine oxidase inhibitors, N-acetylcysteine (NAC), or aldehyde dehydrogenase (ALDH). Intravitreal injection of spermidine into rats significantly increased the permeability of the blood-retinal barrier and decreased the amplitudes of scotopic electroretinogram a- and b-waves. Histological analysis revealed that spermidine induced vacuolation, atrophy, and dropout of RPE cells, leading to the disruption of photoreceptor outer segments. Simultaneous intravitreal administration of NAC and ALDH with spermidine prominently inhibited the functional and morphological changes induced by spermidine. In conclusion, this study demonstrated that the intravitreal administration of spermidine induced RPE cell dysfunction and death followed by photoreceptor degeneration in rats. These effects of spermidine are thought to be mediated by oxidative stress and a toxic aldehyde generated during spermidine oxidation.
Journal of Ocular Pharmacology and Therapeutics | 2015
Shin-Ichiro Hirai; Hiroaki Kurashima; Daisuke Nakamura; Tomoko Komatsu; Yuki Yasuda; Sayo Habashita-Obata; Sanae Ichikawa; Osamu Katsuta; Takao Iwawaki; Kenji Kohno
PURPOSE To investigate the efficacy of 2-phenyl-APB-144 (APB)-induced retinopathy in a rat model and its underlying mechanisms, with a particular focus on retinal pigment epithelium (RPE) degeneration. METHODS Electroretinograms (ERGs) were evaluated in APB-administered rats. In ARPE-19 cells, cathepsin, and autophagy marker LC3 were analyzed by western blotting or immunohistochemistry. Organelle pH alterations were detected by Acridine Orange Staining. Endoplasmic reticulum stress-dependent or -independent cell death signaling was analyzed by reporter gene assays of activating transcription factor 4 (ATF4), immunoglobulin heavy-chain binding protein (BiP), inositol-requiring enzyme 1α (IRE1α), quantitative reverse transcription-polymerase chain reaction of CHOP mRNA, and the effects of pharmacological eukaryotic initiation factor 2α (eIF2α) dephosphorylation inhibitor, Salubrinal. The pharmacological effects of Salubrinal were examined by fluorophotometry, electrophysiology, and histopathology. RESULTS APB-induced ERG amplitude reduction and fluorescein permeability enhancement into the vitreous body of rats were determined. In ARPE-19 cells, APB-induced organelle pH alterations, imbalances of procathepsin and cathepsin expression, the time-dependent accumulation of LC3-II, and the translational activation of ATF4 were determined. Salubrinal protected against APB-induced cell death and inhibited ATF4 downstream factor CHOP mRNA induction. In APB-induced rat retinopathy, systemic Salubrinal alleviated the enhanced fluorescein permeability into the vitreous body from the RPE, the reductions in ERG amplitudes, and RPE degeneration. CONCLUSIONS Organelle pH alterations and autophagy impairments are involved in APB-induced RPE cell death. Inhibition of eIF2α dephosphorylation protected the RPE in vivo and in vitro. These findings suggested that APB-induced retinopathy is a valuable animal model for exploring the mechanism of RPE-driven retinopathy.
Biochemical and Biophysical Research Communications | 1997
Naruhiro Ishida; Shin-Ichiro Hirai; Shiro Mita
Archive | 2004
Masatsugu Nakamura; Shin-Ichiro Hirai
Journal of Ocular Pharmacology and Therapeutics | 2005
Shin-Ichiro Hirai; Megumi Kawahara; Kayoko Sakamoto; Akio Kimura; Masatsugu Nakamura
Archive | 2010
Shin-Ichiro Hirai; Tokiyoshi Matsushita; Yukie Fujita; Hiroaki Kurashima; Kouji Oohashi
Archive | 2010
Shin-Ichiro Hirai; Tokiyoshi Matsushita; Yukie Fujita; Hiroaki Kurashima; Kouji Oohashi
Archive | 2008
Shin-Ichiro Hirai; Atsushi Yoshida
Archive | 2005
Masatsugu Nakamura; Shin-Ichiro Hirai; Keiichi Shibagaki
Archive | 2009
Shin-Ichiro Hirai; Masaaki Sasaoka; Hisayuki Seike